We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
Updated: 12/31/1969
COAST -1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study. A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects With Knee Osteoarthritis Associated With Bone Marrow Lesions.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
Updated: 12/31/1969
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
Status: Enrolling
Updated: 12/31/1969
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
Updated: 12/31/1969
Quality IQ Patient Simulation Physician Practice Measurement and Engagement
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
Updated: 12/31/1969
AAFA™ Fish Oil Nutritional Supplementation to Maintain Body Weight in Patients With Disease-Related Weight Loss
Status: Enrolling
Updated: 12/31/1969
A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss
Updated: 12/31/1969
AAFA™ Fish Oil Nutritional Supplementation to Maintain Body Weight in Patients With Disease-Related Weight Loss
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation of the TITAN™ Total Shoulder System
Updated: 12/31/1969
A Post-Market Observational Study to Evaluate Performance and Safety of the TITAN™ Total Shoulder System
Status: Enrolling
Updated: 12/31/1969
Clinical Evaluation of the TITAN™ Total Shoulder System
Updated: 12/31/1969
A Post-Market Observational Study to Evaluate Performance and Safety of the TITAN™ Total Shoulder System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Evaluation of the TITAN™ Total Shoulder System
Updated: 12/31/1969
A Post-Market Observational Study to Evaluate Performance and Safety of the TITAN™ Total Shoulder System
Status: Enrolling
Updated: 12/31/1969
Clinical Evaluation of the TITAN™ Total Shoulder System
Updated: 12/31/1969
A Post-Market Observational Study to Evaluate Performance and Safety of the TITAN™ Total Shoulder System
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Parabens Flocculation on the Anti Inflammatory Effects of Corticosteroid Injections for Total Knee Arthroplasty
Updated: 12/31/1969
Clinical Significance of Parabens Flocculation on the Anti Inflrammmatory Effects of Corticosteroid Injection Osteoarthritic Knees
Status: Enrolling
Updated: 12/31/1969
Parabens Flocculation on the Anti Inflammatory Effects of Corticosteroid Injections for Total Knee Arthroplasty
Updated: 12/31/1969
Clinical Significance of Parabens Flocculation on the Anti Inflrammmatory Effects of Corticosteroid Injection Osteoarthritic Knees
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia
Updated: 12/31/1969
Improvement in Total Hip Arthroplasty Patient Outcomes With Regional Anesthesia and Multimodal Analgesia: A Retrospective Analysis
Status: Enrolling
Updated: 12/31/1969
Total Hip Arthroplasty Outcomes With Regional and Multimodal Analgesia
Updated: 12/31/1969
Improvement in Total Hip Arthroplasty Patient Outcomes With Regional Anesthesia and Multimodal Analgesia: A Retrospective Analysis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain
Updated: 12/31/1969
The Effect of Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain
Status: Enrolling
Updated: 12/31/1969
Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain
Updated: 12/31/1969
The Effect of Biofreeze® vs. a Placebo on Knee Osteoarthritis Walking Gait Characteristics and Pain
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Closed Suction Drainage in Shoulder Arthroplasty
Updated: 12/31/1969
The Utility of Closed Suction Drainage in Total Shoulder Arthroplasty: A Prospective Analysis.
Status: Enrolling
Updated: 12/31/1969
Closed Suction Drainage in Shoulder Arthroplasty
Updated: 12/31/1969
The Utility of Closed Suction Drainage in Total Shoulder Arthroplasty: A Prospective Analysis.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy of Celecoxib Vs Placebo to Prevent Pain in a Paced Walk
Updated: 9/13/2005
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 Mg Qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
Status: Enrolling
Updated: 9/13/2005
Efficacy of Celecoxib Vs Placebo to Prevent Pain in a Paced Walk
Updated: 9/13/2005
A Double-Blind, Placebo-Controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 Mg Qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
Status: Enrolling
Updated: 9/13/2005
Click here to add this to my saved trials
Intra-articularInjection of Botulinum Toxin Type
Updated: 9/13/2005
Intra-articularInjection of Botulinum Toxin Type a for the Treatment of Chronic Knee Pain: A Randomized, Placebo Controlled, Double Blind Study
Status: Enrolling
Updated: 9/13/2005
Intra-articularInjection of Botulinum Toxin Type
Updated: 9/13/2005
Intra-articularInjection of Botulinum Toxin Type a for the Treatment of Chronic Knee Pain: A Randomized, Placebo Controlled, Double Blind Study
Status: Enrolling
Updated: 9/13/2005
Click here to add this to my saved trials
Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain
Updated: 11/2/2005
Intra-Articular Injection of Botulinum Toxin Type A for the Treatment of Shoulder Pain: A Randomized, Double Blinded, Placebo Controlled Trial
Status: Enrolling
Updated: 11/2/2005
Intra-Articular Injection of Botulinum Toxin Type A for Shoulder Pain
Updated: 11/2/2005
Intra-Articular Injection of Botulinum Toxin Type A for the Treatment of Shoulder Pain: A Randomized, Double Blinded, Placebo Controlled Trial
Status: Enrolling
Updated: 11/2/2005
Click here to add this to my saved trials
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Click here to add this to my saved trials
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Click here to add this to my saved trials
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Study of the Use of Laser Light to Treat Osteoarthritis of the Hand.
Updated: 11/14/2005
Ultra Probe Laser System Osteoarthritis of the Hand Clinical Study.
Status: Enrolling
Updated: 11/14/2005
Click here to add this to my saved trials
Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
Updated: 6/25/2007
Peri-Articular Injections Containing a Corticosteroid During Total Knee Arthroplasty
Status: Enrolling
Updated: 6/25/2007
Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?
Updated: 6/25/2007
Peri-Articular Injections Containing a Corticosteroid During Total Knee Arthroplasty
Status: Enrolling
Updated: 6/25/2007
Click here to add this to my saved trials
Postoperative Function Following Partial and Total Knee Replacement
Updated: 6/26/2007
Postoperative Function Following Partial and Total Knee Replacement
Status: Enrolling
Updated: 6/26/2007
Postoperative Function Following Partial and Total Knee Replacement
Updated: 6/26/2007
Postoperative Function Following Partial and Total Knee Replacement
Status: Enrolling
Updated: 6/26/2007
Click here to add this to my saved trials
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty
Updated: 2/27/2008
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty: A Double-Blinded Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2008
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty
Updated: 2/27/2008
The Role of Intra-Operative Intracapsular Blocks in Post-Operative Pain Management Following Total Knee Arthroplasty: A Double-Blinded Randomized Controlled Trial
Status: Enrolling
Updated: 2/27/2008
Click here to add this to my saved trials
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
Updated: 9/17/2008
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
Status: Enrolling
Updated: 9/17/2008
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
Updated: 9/17/2008
Dose Escalation Study Of Chinese Herbs In Osteoarthritis Of The Knee
Status: Enrolling
Updated: 9/17/2008
Click here to add this to my saved trials
Osteoarthritis Bedside Testing Kit
Updated: 11/19/2008
Development of a Bedside Pain Assessment Kit for Evaluating Effectiveness of Drugs for Osteoarthritis
Status: Enrolling
Updated: 11/19/2008
Osteoarthritis Bedside Testing Kit
Updated: 11/19/2008
Development of a Bedside Pain Assessment Kit for Evaluating Effectiveness of Drugs for Osteoarthritis
Status: Enrolling
Updated: 11/19/2008
Click here to add this to my saved trials
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
Updated: 1/27/2009
An Open Label Trial for Treating Carpometacarpal Osteoarthritis: A Pilot Study Sub Study: Validation of the Strength-Dexterity Test in Subjects Without Carpometacarpal Osteoarthritis
Status: Enrolling
Updated: 1/27/2009
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot Study
Updated: 1/27/2009
An Open Label Trial for Treating Carpometacarpal Osteoarthritis: A Pilot Study Sub Study: Validation of the Strength-Dexterity Test in Subjects Without Carpometacarpal Osteoarthritis
Status: Enrolling
Updated: 1/27/2009
Click here to add this to my saved trials
Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Updated: 2/5/2009
Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Status: Enrolling
Updated: 2/5/2009
Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Updated: 2/5/2009
Restoration of Leg Length, Offset, and Center of Rotation in Total Hip Replacement
Status: Enrolling
Updated: 2/5/2009
Click here to add this to my saved trials
A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
Updated: 2/18/2009
Study Evaluating Cura-100 in Rheumatoid Arthritis and Osteoarthritis
Status: Enrolling
Updated: 2/18/2009
A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis
Updated: 2/18/2009
Study Evaluating Cura-100 in Rheumatoid Arthritis and Osteoarthritis
Status: Enrolling
Updated: 2/18/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the Hip
Updated: 2/19/2009
A 13-Week, Phase 3, Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo Bid and Naproxen 500 mg Bid, Controlled Study on the Efficacy on Signs and Symptoms, and Safety of Naproxcinod (HCT3012) 750 mg Bid, in Patients With Osteoarthritis of the Hip
Status: Enrolling
Updated: 2/19/2009
Click here to add this to my saved trials